Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway

  • Authors:
    • Jingwen Chen
    • Ye Wei
    • Qingyang Feng
    • Li Ren
    • Guodong He
    • Wenju Chang
    • Dexiang Zhu
    • Tuo Yi
    • Qi Lin
    • Wentao Tang
    • Jianmin Xu
    • Xinyu Qin
  • View Affiliations

  • Published online on: February 1, 2016     https://doi.org/10.3892/ijo.2016.3366
  • Pages: 1628-1638
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ribosomal protein S15A (RPS15A), which has been identified as a highly conserved 40S ribosomal protein, is essential for cell survival and proliferation. The present study evaluated the functional role of RPS15A in colorectal cancer (CRC), and our investigation found that RPS15A was highly expressed in a cohort of human CRC. High RPS15A expression was associated with older age (P=0.035), not receiving preoperative neoadjuvant treatment (P=0.048), higher primary pN stage (P=0.007) and slightly more synchronous distant metastases (P=0.058). The Cox univariate and multivariate hazard regression analysis revealed that higher expression of RPS15A led to a reduction of overall survival rate in CRC, indicating that enhanced RPS15A expression functions as an independent risk factor for the prognosis of CRC patients (P<0.001). Cell based analysis showed that RPS15A was widely expressed in human CRC cell lines. Knockdown of RPS15A significantly suppressed cell proliferation and colony formation in HCT116 and DLD-1 cells, and induced cell cycle arrest at G0/G1 phase. Genechip analysis suggested that knockdown of RPS15A might affect the p53 signaling pathway. Further study indicated that RPS15A knockdown upregulated p53 and p21 expression whereas downregulated CDK1 expression. In summary, the present study identified RPS15A as a novel univariate prognostic factor predicting a poor outcome in CRC patients. The RPS15A overexpression induced by malignant transformation of CRC might function through the p53 signaling pathway.

References

1 

Sánchez-Tena S, Vizán P, Dudeja PK, Centelles JJ and Cascante M: Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1. Biochim Biophys Acta. 1832:2264–2270. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Labianca R, Nordlinger B, Beretta GD, Brouquet A and Cervantes A; ESMO Guidelines Working Group. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 21(Suppl 5): v70–v77. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Wolpin BMMJ, Meyerhardt JA, Mamon HJ and Mayer RJ: Adjuvant treatment of colorectal cancer. CA Cancer J Clin. 57:168–185. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Uechi T, Nakajima Y, Nakao A, Torihara H, Chakraborty A, Inoue K and Kenmochi N: Ribosomal protein gene knockdown causes developmental defects in zebrafish. PLoS One. 1:e372006. View Article : Google Scholar : PubMed/NCBI

5 

Nakao A, Yoshihama M and Kenmochi N: RPG: The Ribosomal Protein Gene database. Nucleic Acids Res. 32:D168–D170. 2004. View Article : Google Scholar :

6 

Lambertsson A: The minute genes in Drosophila and their molecular functions. Adv Genet. 38:69–134. 1998. View Article : Google Scholar : PubMed/NCBI

7 

Oliver ERST, Saunders TL, Tarlé SA and Glaser T: Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development. 131:3907–3920. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Jiménez L, Becerra A and Landa A: Cloning, expression and partial characterization of a gene encoding the S15a ribosomal protein of Taenia solium. Parasitol Res. 92:414–420. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Akiyama N, Matsuo Y, Sai H, Noda M and Kizaka-Kondoh S: Identification of a series of transforming growth factor beta-responsive genes by retrovirus-mediated gene trap screening. Mol Cell Biol. 20:3266–3273. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Xu M, Wang Y, Chen L, Pan B, Chen F, Fang Y, Yu Z and Chen G: Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro. Gene. 536:84–89. 2014. View Article : Google Scholar

11 

Zhao X, Shen L, Feng Y, Yu H, Wu X, Chang J, Shen X, Qiao J and Wang J: Decreased expression of RPS15A suppresses proliferation of lung cancer cells. Tumour Biol. 36:6733–6734. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Bordeleau ME, Robert F, Gerard B, Lindqvist L, Chen SM, Wendel HG, Brem B, Greger H, Lowe SW, Porco JA Jr, et al: Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest. 118:2651–2660. 2008.PubMed/NCBI

13 

Hagner PR, Mazan-Mamczarz K, Dai B, Balzer EM, Corl S, Martin SS, Zhao XF and Gartenhaus RB: Ribosomal protein S6 is highly expressed in non-Hodgkin lymphoma and associates with mRNA containing a 5′ terminal oligopyrimidine tract. Oncogene. 30:1531–1541. 2011. View Article : Google Scholar :

14 

Panwalkar A, Verstovsek S and Giles FJ: Mammalian target of rapamycin inhibition as therapy for hematologic malignancies. Cancer. 100:657–666. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Venticinque L, Jamieson KV and Meruelo D: Interactions between laminin receptor and the cytoskeleton during translation and cell motility. PLoS One. 6:e158952011. View Article : Google Scholar : PubMed/NCBI

16 

Õunap K, Käsper L, Kurg A and Kurg R: The human WBSCR22 protein is involved in the biogenesis of the 40S ribosomal subunits in mammalian cells. PLoS One. 8:e756862013. View Article : Google Scholar : PubMed/NCBI

17 

Kim SH, Jang YH, Chau GC, Pyo S and Um SH: Prognostic significance and function of phosphorylated ribosomal protein S6 in esophageal squamous cell carcinoma. Mod Pathol. 26:327–335. 2013. View Article : Google Scholar

18 

Zhang C, Zhang T, Song E, Himaya SW, Chen X and Zheng L: Ribosomal protein S15A augments human osteosarcoma cell proliferation in vitro. Cancer Biother Radiopharm. 29:451–456. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2016
Volume 48 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Chen, J., Wei, Y., Feng, Q., Ren, L., He, G., Chang, W. ... Qin, X. (2016). Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway. International Journal of Oncology, 48, 1628-1638. https://doi.org/10.3892/ijo.2016.3366
MLA
Chen, J., Wei, Y., Feng, Q., Ren, L., He, G., Chang, W., Zhu, D., Yi, T., Lin, Q., Tang, W., Xu, J., Qin, X."Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway". International Journal of Oncology 48.4 (2016): 1628-1638.
Chicago
Chen, J., Wei, Y., Feng, Q., Ren, L., He, G., Chang, W., Zhu, D., Yi, T., Lin, Q., Tang, W., Xu, J., Qin, X."Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway". International Journal of Oncology 48, no. 4 (2016): 1628-1638. https://doi.org/10.3892/ijo.2016.3366